Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

Cited by (1,093)

Items 1,001–1,093 of 1,093

1. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes
   Feldman, Becca S., Cohen-Stavi, Chandra J., Leibowitz, Morton, Hoshen, Moshe B., Singer, Shepherd R., Bitterman, Haim, Lieberman, Nicky, Balicer, Ran D. · 2014 · PLoS ONE
2. Efficacy and Safety Profile Evaluation of Acarbose Alone and in Association With Other Antidiabetic Drugs: A Systematic Review
   Derosa, Giuseppe, Maffioli, Pamela · 2012 · Clinical Therapeutics
3. Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease
   Scheen, André J · 2013 · Expert Opinion on Drug Metabolism & Toxicology
4. Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study
   Zafar, A., Stone, M. A., Davies, M. J., Khunti, K. · 2015 · Diabetic Medicine
5. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes
   Davis, Stephen N., Mann, Stephanie, Briscoe, Vanessa J., Ertl, Andrew C., Tate, Donna B. · 2009 · Diabetes
6. The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial
   Nguyen, Tu N., Harris, Katie, Woodward, Mark, Chalmers, John, Cooper, Mark, Hamet, Pavel, Harrap, Stephen, Heller, Simon, MacMahon, Stephen, Mancia, Giuseppe et al. · 2021 · Diabetes Care
7. Cost-effectiveness of an electronic medical record based clinical decision support system
   Gilmer, Todd P., O'Connor, Patrick J., Sperl‐Hillen, JoAnn M., Rush, William A., Johnson, Paul E., Amundson, Gerald H., Asche, Stephen E., Ekstrom, Heidi L. · 2012 · Health Services Research
8. Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
   Raz, Itamar · 2013 · Diabetes Care
9. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes
   Khunti, Kamlesh, Alsifri, Saud, Aronson, Ronnie, Cigrovski Berković, Maja, Enters-Weijnen, Catherine, Forsén, Tom, Galstyan, Gagik, Geelhoed-Duijvestijn, Petronella, Goldfracht, Margalit, Gydesen, Helge et al. · 2017 · Diabetes Research and Clinical Practice
10. One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
    Buysschaert, M., Preumont, V., Oriot, P.R., Paris, I., Ponchon, M., Scarnière, D., Selvais, P. · 2010 · Diabetes & Metabolism
11. Glycated hemoglobin and outcomes in patients with advanced diabetic chronic kidney disease
    Kuo, I-Ching, Lin, Hugo You-Hsien, Niu, Sheng-Wen, Hwang, Daw-Yang, Lee, Jia-Jung, Tsai, Jer-Chia, Hung, Chi-Chih, Hwang, Shang-Jyh, Chen, Hung-Chun · 2016 · Scientific Reports
12. Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association
    Khan, Sadiya S., Breathett, Khadijah, Braun, Lynne T., Chow, Sheryl L., Gupta, Deepak K., Lekavich, Carolyn, Lloyd-Jones, Donald M., Ndumele, Chiadi E., Rodriguez, Carlos J., Allen, Larry A. et al. · 2025 · Circulation
13. Epigenetic Signatures and Vascular Risk in Type 2 Diabetes: A Clinical Perspective
    Paneni, Francesco, Costantino, Sarah, Volpe, Massimo, Lüscher, Thomas Felix, Cosentino, Francesco · 2013 · Atherosclerosis
14. Long-term glycemic variability and vascular complications in type 2 diabetes: post hoc analysis of the field study
    Scott, Emma S, Januszewski, Andrzej S, O’Connell, Rachel, Fulcher, Gregory, Scott, Russell, Kesaniemi, Antero, Wu, Linda, Colagiuri, Stephen, Keech, Anthony, Jenkins, Alicia J · 2020 · The Journal of Clinical Endocrinology & Metabolism
15. Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
    Dailey, George · 2011 · Clinical Therapeutics
16. Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis
    Yoshida, Yilin, Joshi, Preeti, Barri, Saba, Wang, Jia, Corder, Amy L., O'Connell, Samantha S., Fonseca, Vivian A. · 2022 · Journal of Diabetes and its Complications
17. Cardiac autonomic regulation and repolarization during acute experimental hypoglycemia in type 2 diabetes
    Chow, Elaine, Bernjak, Alan, Walkinshaw, Emma, Lubina-Solomon, Alexandra, Freeman, Jenny, Macdonald, Ian A., Sheridan, Paul J., Heller, Simon R. · 2017 · Diabetes
18. Cardiovascular protective properties of GLP-1 receptor agonists: more than just diabetic and weight loss drugs
    Le, Richard, Nguyen, Mau T., Allahwala, Momina A., Psaltis, James P., Marathe, Chinmay S., Marathe, Jessica A., Psaltis, Peter J. · 2024 · Journal of Clinical Medicine
19. Effect of hospital-based telephone coaching on glycaemic control and adherence to management guidelines in type 2 diabetes, a randomised controlled trial
    Varney, J. E., Weiland, T. J., Inder, W. J., Jelinek, G. A. · 2014 · Internal Medicine Journal
20. Telemedicine compared with standard care in type 2 diabetes mellitus: A randomized trial in an outpatient clinic
    Rasmussen, Ole W, Lauszus, FF, Loekke, M · 2016 · Journal of Telemedicine and Telecare
21. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC study
    Bebu, Ionut, Braffett, Barbara H., Orchard, Trevor J., Lorenzi, Gayle M., Lachin, John M., the DCCT/EDIC Research Group · 2019 · Diabetes Care
22. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis
    Fitzpatrick, Claire, Chatterjee, Sudesna, Seidu, Samuel, Bodicoat, Danielle H., Ng, G Andre, Davies, Melanie J., Khunti, Kamlesh · 2018 · Diabetes, Obesity and Metabolism
23. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials
    Fang, Hong-Juan, Zhou, Yu-Hao, Tian, Yong-Ji, Du, Han-Yang, Sun, Yan-Xia, Zhong, Li-Yong · 2016 · International Journal of Cardiology
24. Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
    Ohkuma, Toshiaki, Jun, Min, Rodgers, Anthony, Cooper, Mark E., Glasziou, Paul, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Marre, Michel, Neal, Bruce et al. · 2019 · Hypertension
25. Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes.
    Greene, Stephen J., Vaduganathan, Muthiah, Khan, Muhammad Shahzeb, Bakris, George L., Weir, Matthew R., Seltzer, Jonathan H., Sattar, Naveed, McGuire, Darren K., Januzzi, James L., Stockbridge, Norman et al. · 2018 · Journal of the American College of Cardiology
26. A1C targets should be personalized to maximize benefits while limiting risks
    Riddle, Matthew C., Gerstein, Hertzel C., Holman, Rury R., Inzucchi, Silvio E., Zinman, Bernard, Zoungas, Sophia, Cefalu, William T. · 2018 · Diabetes Care
27. High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network
    Karter, Andrew J, Lipska, Kasia J, O’Connor, Patrick J., Liu, Jennifer Y., Moffet, Howard H, Schroeder, Emily B., Lawrence, Jean M., Nichols, Gregory A., Newton, Katherine M, Pathak, Ram D. et al. · 2017 · Journal of Diabetes and its Complications
28. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis
    Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., Meier, C. R. · 2014 · Diabetes, Obesity and Metabolism
29. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
    Bain, Stephen C., Bekker Hansen, Brian, Hunt, Barnaby, Chubb, Barrie, Valentine, William J. · 2020 · Journal of Medical Economics
30. Diabetes and Cardiovascular Disease Prevention in Older Adults
    Cigolle, Christine T., Blaum, Caroline S., Halter, Jeffrey B. · 2009 · Clinics in Geriatric Medicine
31. An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment
    Makam, Anil N., Nguyen, Oanh K. · 2017 · Circulation
32. Does Clinical Inertia Vary by Personalized A1C Goal? A Study of Predictors and Prevalence of Clinical Inertia In A U.S. Managed-Care Setting
    Lin, Jay, Zhou, Steve, Wei, Wenhui, Pan, Chunshen, Lingohr-Smith, Melissa, Levin, Philip · 2016 · Endocrine Practice
33. Diabetes after Bariatric Surgery
    Shah, Ankit, Laferrère, Blandine · 2017 · Canadian Journal of Diabetes
34. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
    McCoy, Rozalina G, Lipska, Kasia J, Van Houten, Holly K, Shah, Nilay D · 2020 · BMJ Open Diabetes Research & Care
35. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus
    Yandrapalli, Srikanth, Jolly, George, Horblitt, Adam, Sanaani, Abdallah, Aronow, Wilbert S. · 2017 · Postgraduate Medicine
36. GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
    Bertoccini, Laura, Baroni, Marco Giorgio · 2020 · Advances in Experimental Medicine and Biology
37. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals
    Leiter, Lawrence A., Boras, Damir, Woo, Vincent C. · 2014 · Canadian Journal of Diabetes
38. Patient characteristics associated with severe hypoglycemia in a type 2 diabetes cohort in a large, integrated health care system from 2006 to 2015
    Misra-Hebert, Anita D., Pantalone, Kevin M., Ji, Xinge, Milinovich, Alex, Dey, Tanujit, Chagin, Kevin M., Bauman, Janine M., Kattan, Michael W., Zimmerman, Robert S. · 2018 · Diabetes Care
39. Direct cardiovascular effects of glucagon like peptide-1
    Sheikh, Asfandyar · 2013 · Diabetology & Metabolic Syndrome
40. Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
    Viljoen, Adie, Hoxer, Christina S., Johansen, Pierre, Malkin, Samuel, Hunt, Barnaby, Bain, Stephen C. · 2019 · Diabetes, Obesity and Metabolism
41. The role of GLP-1 receptor agonists in managing type 2 diabetes
    Nachawi, Noura, Rao, Pratibha PR, Makin, Vinni · 2022 · Cleveland Clinic Journal of Medicine
42. Cardiovascular Benefits of GLP-1-BasedTherapies in Patients with Diabetes Mellitus Type 2: Effects on Endothelial and Vascular Dysfunction beyond Glycemic Control
    Forst, Thomas, Weber, Matthias M., Pfützner, Andreas · 2012 · Experimental Diabetes Research
43. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
    Gorenek, Bulent, Boriani, Giuseppe, Dan, Gheorge-Andrei, Fauchier, Laurent, Fenelon, Guilherme, Huang, He, Kudaiberdieva, Gulmira, Lip, Gregory Y H, Mahajan, Rajiv, Potpara, Tatjana et al. · 2018 · EP Europace
44. Obesity and diabetes: the links and common approaches
    Haslam, David · 2010 · Primary Care Diabetes
45. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
    Lund, S. S, Tarnow, L., Frandsen, M., Nielsen, B. B, Hansen, B. V, Pedersen, O., Parving, H.-H., Vaag, A. A · 2009 · BMJ
46. Multiple pathologies are common in Alzheimer patients in clinical trials
    Wang, B. W., Lu, E., Mackenzie, I. R. A., Assaly, M., Jacova, C., Lee, P. E., Beattie, B. L., Hsiung, G. Y. R. · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
47. Patient empowerment and optimal glycemic control
    White, Russell D. · 2012 · Current Medical Research and Opinion
48. Time in range: How to measure it, how to report it, and its practical application in clinical decision-making
    Wright, Eugene E., Morgan, Kayla, Fu, Danny K., Wilkins, Nick, Guffey, William J. · 2020 · Clinical Diabetes
49. Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: A population-based study
    Lega, Iliana C., Campitelli, Michael A., Austin, Peter C., Na, Yingbo, Zahedi, Afshan, Leung, Freda, Yu, Catherine, Bronskill, Susan E., Rochon, Paula A., Lipscombe, Lorraine L. · 2021 · Diabetologia
50. Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist
    Young, Malcolm A., Wald, Jeffrey A., Matthews, Jessica E., Scott, Rhona, Hodge, Rebecca J., Zhi, Hui, Reinhardt, Rickey R. · 2014 · Postgraduate Medicine
51. Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study
    Kaze, Arnaud D, Santhanam, Prasanna, Erqou, Sebhat, Ahima, Rexford S, Echouffo-Tcheugui, Justin Basile · 2020 · BMJ Open Diabetes Research & Care
52. Significance of Glycemic Variability in Diabetes Mellitus
    Kusunoki, Yoshiki, Konishi, Kosuke, Tsunoda, Taku, Koyama, Hidenori · 2022 · Internal Medicine
53. Colesevelam for type 2 diabetes mellitus: an abridged Cochrane review
    Ooi, C. P., Loke, S. C. · 2014 · Diabetic Medicine
54. Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes
    Chow, Lisa S, Zmora, Rachel, Ma, Sisi, Seaquist, Elizabeth R, Schreiner, Pamela J · 2018 · BMJ Open Diabetes Research & Care
55. Economic burden of hypoglycemia in patients with type 2 diabetes
    Liu, Shuqian, Zhao, Yingnan, Hempe, James M, Fonseca, Vivian, Shi, Lizheng · 2012 · Expert Review of Pharmacoeconomics & Outcomes Research
56. Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
    Jung, Min Jung, Kwon, Su Kyoung · 2014 · Endocrinology and Metabolism
57. Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profile
    Muzurović, Emir, Mikhailidis, Dimitri P · 2020 · Expert Opinion on Pharmacotherapy
58. Culturally tailored self-management interventions for South Asians with type 2 diabetes: A systematic review
    Navodia, Nevin, Wahoush, Olive, Tang, Tricia, Yost, Jennifer, Ibrahim, Sarah, Sherifali, Diana · 2019 · Canadian Journal of Diabetes
59. Increasing Trend in the Number of Severe Hypoglycemia Patients in Korea
    Kim, Jin Taek, Oh, Tae Jung, Lee, Ye An, Bae, Jun Ho, Kim, Hyo Jeong, Jung, Hye Seung, Cho, Young Min, Park, Kyong Soo, Lim, Soo, Jang, Hak Chul et al. · 2011 · Diabetes & Metabolism Journal
60. The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel, Miossec, Patrick, Larsen, Bjarne Due, Werner, Ulrich, Knop, Filip K · 2014 · Expert Opinion on Drug Discovery
61. Targeted learning with daily EHR data
    Sofrygin, Oleg, Zhu, Zheng, Schmittdiel, Julie A., Adams, Alyce S., Grant, Richard W., van der Laan, Mark J., Neugebauer, Romain · 2019 · Statistics in Medicine
62. Should metformin remain first-line medical therapy for patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease? An alternative approach
    Harrington, Josephine L., de Albuquerque Rocha, Natalia, Patel, Kershaw V., Verma, Subodh, McGuire, Darren K. · 2018 · Current Diabetes Reports
63. Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!
    Ried‐Larsen, Mathias, MacDonald, Christopher S., Johansen, Mette Y., Hansen, Katrine B., Christensen, Robin, Almdal, Thomas P., Pedersen, Bente K., Karstoft, Kristian · 2018 · Diabetes/Metabolism Research and Reviews
64. Increasing Peripheral Insulin Sensitivity by Protein Tyrosine Phosphatase 1B Deletion Improves Control of Blood Pressure in Obesity
    de Chantemèle, Eric J. Belin, Ali, Mohammed Irfan, Mintz, James D., Rainey, William E., Tremblay, Michel L., Fulton, David J., Stepp, David W. · 2012 · Hypertension
65. Baroreflex sensitivity impairment during hypoglycemia: implications for cardiovascular control
    Rao, Ajay D., Bonyhay, Istvan, Dankwa, Joel, Baimas-George, Maria, Kneen, Lindsay, Ballatori, Sarah, Freeman, Roy, Adler, Gail K. · 2016 · Diabetes
66. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments
    Gore, M. O., McGuire, D. K. · 2011 · European Heart Journal
67. Personalised treatment targets in type 2 diabetes patients: The Dutch approach
    Boels, Anne Meike, Hart, Huberta E., Rutten, Guy E., Vos, Rimke C. · 2017 · Primary Care Diabetes
68. Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
    Heymsfield, Steven B., Raji, Annaswamy, Gallo, Silvina, Liu, Jie, Pong, Annpey, Hannachi, Hakima, Terra, Steven G. · 2020 · Obesity
69. Effect of glycemic control and disease duration on cardiac autonomic function and oxidative stress in type 2 diabetes mellitus
    Verma, Shalini, Alam, Rizwan, Ahmad, Irshad, Singla, Deepika, Ali, Kamran, Hussain, Mohammed E. · 2018 · Journal of Diabetes & Metabolic Disorders
70. The role of anti-obesity medication in prevention of diabetes and its complications
    Oh, Tae Jung · 2019 · Journal of Obesity & Metabolic Syndrome
71. Diabetische Neuropathie und diabetischer Fuß (Update 2019)
    Lechleitner, Monika, Abrahamian, Heidemarie, Francesconi, Claudia, Kofler, Markus, Sturm, Wolfgang, Köhler, Gerd · 2019 · Wiener klinische Wochenschrift
72. Cardiovascular outcome studies with incretin-based therapies: Comparison between DPP-4 inhibitors and GLP-1 receptor agonists
    Scheen, André J. · 2017 · Diabetes Research and Clinical Practice
73. Hospital utilization for hypoglycemia among patients with type 2 diabetes using pooled data from six health systems
    Pilla, Scott J, Kraschnewski, Jennifer L, Lehman, Erik B, Kong, Lan, Francis, Erica, Poger, Jennifer M, Bryce, Cindy L, Maruthur, Nisa M, Yeh, Hsin-Chieh · 2021 · BMJ Open Diabetes Research & Care
74. An Assessment of How Clinicians and Staff Members Use a Diabetes Artificial Intelligence Prediction Tool: Mixed Methods Study
    Liaw, Winston R, Ramos Silva, Yessenia, Soltero, Erica G, Krist, Alex, Stotts, Angela L · 2023 · JMIR AI
75. Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: systematic review and meta-analysis
    Bilal, Anika, Yi, Fanchao, Gonzalez, Gonzalo Romero, Ali, Mehreen, Im, KyungAh, Ruff, Christian T., Thethi, Tina K., Pratley, Richard E. · 2024 · Journal of Diabetes and its Complications
76. Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes
    Hoffman, Emily G., D’Souza, Ninoschka C., Liggins, Richard T., Riddell, Michael C. · 2024 · Frontiers in Pharmacology
77. How to perform better intervention to prevent and control diabetic retinopathy among patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Yusufu, Mayinuer, Zhang, Xuxi, Sun, Xinying, Raat, Hein, Wang, Ningli · 2019 · Diabetes Research and Clinical Practice
78. Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus
    Tschöpe, Diethelm, Bramlage, Peter, Schneider, Steffen, Gitt, Anselm K · 2016 · Diabetes and Vascular Disease Research
79. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China
    Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin · 2023 · Diabetes Therapy
80. Therapy of Type 2 Diabetes
    Landgraf, Rüdiger, Aberle, Jens, Birkenfeld, Andreas L., Gallwitz, Baptist, Kellerer, Monika, Klein, Harald, Müller-Wieland, Dirk, Nauck, Michael A., Wiesner, Tobias, Siegel, Erhard · 2022 · Experimental and Clinical Endocrinology & Diabetes
81. Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection
    Caruso, Irene, Cignarelli, Angelo, Natalicchio, Annalisa, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco · 2020 · Metabolism
82. Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study
    Kaewbut, Piranee, Kosachunhanun, Natapong, Phrommintikul, Arintaya, Chinwong, Dujrudee, Hall, John J., Chinwong, Surarong · 2022 · Healthcare
83. Control Status of Atherosclerotic Cardiovascular Risk Factors Among Japanese High-Risk Subjects:Analyses of a Japanese Health Check Database from 2008 to 2011
    Hasegawa, Koji, Tsukamoto, Kazuhisa, Kunimi, Motoei, Asahi, Koichi, Iseki, Kunitoshi, Moriyama, Toshiki, Yamagata, Kunihiro, Tsuruya, Kazuhiko, Fujimoto, Shouichi, Narita, Ichiei et al. · 2016 · Journal of Atherosclerosis and Thrombosis
84. Factors influencing hospitalization or emergency department visits and mortality in type 2 diabetes following the onset of new cardiovascular diagnoses in a population-based study
    Agvall, Björn, Jonasson, Junmei Miao, Galozy, Alexander, Halling, Anders · 2024 · Cardiovascular Diabetology
85. Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
    Fuentes, B., Amaro, S., Alonso de Leciñana, M., Arenillas, J.F., Ayo-Martín, O., Castellanos, M., Freijo, M., García-Pastor, A., Gomis, M., Gómez Choco, M. et al. · 2021 · Neurología
86. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco, Grant, Peter J, Aboyans, Victor, Bailey, Clifford J, Ceriello, Antonio, Delgado, Victoria, Federici, Massimo, Filippatos, Gerasimos, Grobbee, Diederick E, Hansen, Tina Birgitte et al. · 2020 · European Heart Journal
87. Update in diabetes and cardiovascular disease: synthesizing the evidence from recent trials of glycemic control to prevent cardiovascular disease.
    Park, Lee, Wexler, Deborah · 2010 · Current Opinion in Lipidology
88. Factors associated with prolonged poor glycemic control in type 2 diabetes mellitus (T2DM) patients followed in the Department of Internal Medicine at the Yalgado Ouedraogo teaching hospital, Ouagadougou (Burkina Faso)
    Traoré, Solo, Guira, Oumar, Zoungrana, Lassané, Sagna, Yempabou, Bognounou, Réné, B. Paré, Constant, Dabourou, Désiré L., Séré, Lassina, Zemba, Daniel, Dembélé, Laurette S. et al. · 2021 · Open Journal of Internal Medicine
89. Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
    Sanon, Vani, Patel, Shalin, Sanon, Saurabh, Rodriguez, Ruben, Pham, Son, Chilton, Robert · 2017 · Therapeutics and Clinical Risk Management
90. DreamTel; diabetes risk evaluation and management tele-monitoring study protocol
    Tobe, Sheldon W, Wentworth, Joan, Ironstand, Laurie, Hartman, Susan, Hoppe, Jackie, Whiting, Judi, Kennedy, Janice, McAllister, Colin, Kiss, Alex, Perkins, Nancy et al. · 2009 · BMC Endocrine Disorders
91. Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
    Coca, Steven G., Ismail-Beigi, Faramarz, Haq, Nowreen, Krumholz, Harlan M., Parikh, Chirag R. · 2012 · Archives of Internal Medicine
92. The effect of dietary nitrate supplementation on the oxygen cost of cycling, walking performance and resting blood pressure in individuals with chronic obstructive pulmonary disease: A double blind placebo controlled, randomised control trial
    Shepherd, Anthony I., Wilkerson, Daryl P., Dobson, Lee, Kelly, James, Winyard, Paul G., Jones, Andrew M., Benjamin, Nigel, Shore, Angela C., Gilchrist, Mark · 2015 · Nitric Oxide
93. Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study
    The Diabetes Prevention Program Outcomes Study Research Group; prepared on behalf of the DPPOS Research Group, Orchard, T. J., Temprosa, M., Barrett‐Connor, E., Fowler, S. E., Goldberg, R. B., Mather, K. J., Marcovina, S. M., Montez, M., Ratner, R. E. et al. · 2013 · Diabetic Medicine